Civil Action - AAPS vs FDA on Pediatric Rule. 2002
Commission consultation on a draft proposal for a European Parliament and Council Regulation (EC) on medicinal products for paediatric use. March 2004.
Department of Health and Human Services, United States Food and Drug Administration. Statement of the FDA Commissioner Mark B. McClellan, M.D., Ph.D., on the signing of the Pediatric Research Equity Act of 2003. 3 Dec 2003.
Directive 2001/20/EC Of The European Parliament And Of The Council Of 4 April 2001
E11 Clinical Investigation of
Medicinal Products in the Pediatric Population. Guidance for Industry
EMEA. Concept Paper on the Development of Committee for Proprietary Medicinal
Products (CPMP) Guidance on Formulations of Choice for the Paediatric Population. 2003
EMEA. CPMP. Note for Guidance on the Clinical Investigation of
Medicinal Products in Children. 1997
EMEA. ICH Topic E11. Note for Guidance on Clinical Investigation of
Medicinal Products in the Paediatric Population. 1999
EMEA. Medicines for Children - The European Paediatric Initiative. July 2003.
European Commission. Better Medicines for Children. Proposed regulatory actions on paediatric medicinal products. Brussels, February, 2002.
Food and Drug Modernization Act of 1997 (FDAMA). (See Section 111: Pediatric studies of drugs)
Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in
Pediatric Patients; Final Rule
The Pediatric Exclusivity
Provision. Status Report to Congress. January 2001
United States Pediatric Research Equity Act of 2003
EMEA. Work Programme for the Paediatric Expert Group (PEG) 2004-2005
EMEA. Work Programme for the Paediatric Expert Group (PEG) 2003
EMEA. CPMP Paediatric Expert Group (PEG). Concept paper on the mandate, composition and functioning of the group. June 2001. CPMP/14691/01 rev.1.